HomeLEXX • NASDAQ
add
Lexaria Bioscience Corp
Previous close
$3.09
Day range
$3.06 - $3.68
Year range
$0.65 - $6.85
Market cap
44.97M USD
Avg Volume
279.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Feb 2024info | Y/Y change |
---|---|---|
Revenue | 145.00K | 624.09% |
Operating expense | 813.00K | -39.36% |
Net income | -649.54K | 49.96% |
Net profit margin | -447.96 | 93.09% |
Earnings per share | — | — |
EBITDA | -652.07K | 49.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Feb 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.79M | 35.41% |
Total assets | 6.35M | 30.84% |
Total liabilities | 204.20K | -8.48% |
Total equity | 6.15M | — |
Shares outstanding | 12.89M | — |
Price to book | 5.83 | — |
Return on assets | -33.47% | — |
Return on capital | -34.00% | — |
Cash Flow
Net change in cash
(USD) | Feb 2024info | Y/Y change |
---|---|---|
Net income | -649.54K | 49.96% |
Cash from operations | -619.61K | 49.55% |
Cash from investing | -56.99K | -74.37% |
Cash from financing | 3.45M | — |
Net change in cash | 2.75M | 318.19% |
Free cash flow | -452.49K | 42.00% |
About
Founded
2004
Website
Employees
5